Metformin alters the faecal microbiome of an azoxymethane-induced colorectal neoplasia mouse model
The aim is to investigate the impact of low-dose metformin on the gut microbiome of male C57BL/6 as a potential treatment against colorectal carcinogenesis induced by azoxymethane (AOM).